Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Hunzelmann

Showing results (101-110 of 144) with videos related to

Pageof 15
Sort By:
Chest|August 15, 2023
Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic SclerosisPia Moinzadeh, Francesco Bonella, Max Oberste, et al.
RMD Open|August 13, 2025
Assessing the <i>MUC5B</i> promoter variant in a large cohort of systemic sclerosis-associated interstitial lung diseaseCarlos Rosa-Baez, Carlos Rangel-Pelaez, Inmaculada Rodriguez-Martin, et al.
NPJ Genomic Medicine|October 5, 2022
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosisMartin Kerick, Marialbert Acosta-Herrera, Carmen Pilar Simeón-Aznar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 14, 2025
Distinct effects of complement C4A and C4B copy number in Systemic Sclerosis serological and clinical subtypesJavier Martínez-López, Carlos Rangel-Peláez, Inmaculada Rodriguez-Martin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 8, 2024
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedemaRobert Knobler, Marija Geroldinger-Simić, Alexander Kreuter, et al.
Arthritis and Rheumatism|August 29, 2013
A regulatory variant in CCR6 is associated with susceptibility to antitopoisomerase-positive systemic sclerosisEugénie Koumakis, Matthieu Bouaziz, Philippe Dieudé, et al.
Arthritis Research & Therapy|June 27, 2012
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosisMaría Teruel, Carmen P Simeon, Jasper Broen, et al.
Rheumatology (Oxford, England)|April 11, 2026
Novel pleiotropic loci links vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenonCarlos Rangel-Peláez, Inmaculada Rodriguez-Martin, Carlos Rosa-Baez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 1, 2017
Analysis of ATP8B4 F436L Missense Variant in a Large Systemic Sclerosis CohortElena López-Isac, Lara Bossini-Castillo, Ana B Palma, et al.
The Lancet. Rheumatology|April 18, 2026
Sex-specific autosomal susceptibility loci in systemic sclerosis: a genome-wide association studyInmaculada Rodriguez-Martin, Martin Kerick, Carlos Rangel-Peláez, et al.
Pageof 15

Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Chest|August 15, 2023
Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic SclerosisPia Moinzadeh, Francesco Bonella, Max Oberste, et al.
RMD Open|August 13, 2025
Assessing the <i>MUC5B</i> promoter variant in a large cohort of systemic sclerosis-associated interstitial lung diseaseCarlos Rosa-Baez, Carlos Rangel-Pelaez, Inmaculada Rodriguez-Martin, et al.
NPJ Genomic Medicine|October 5, 2022
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosisMartin Kerick, Marialbert Acosta-Herrera, Carmen Pilar Simeón-Aznar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 14, 2025
Distinct effects of complement C4A and C4B copy number in Systemic Sclerosis serological and clinical subtypesJavier Martínez-López, Carlos Rangel-Peláez, Inmaculada Rodriguez-Martin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 8, 2024
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedemaRobert Knobler, Marija Geroldinger-Simić, Alexander Kreuter, et al.
Arthritis and Rheumatism|August 29, 2013
A regulatory variant in CCR6 is associated with susceptibility to antitopoisomerase-positive systemic sclerosisEugénie Koumakis, Matthieu Bouaziz, Philippe Dieudé, et al.
Arthritis Research & Therapy|June 27, 2012
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosisMaría Teruel, Carmen P Simeon, Jasper Broen, et al.
Rheumatology (Oxford, England)|April 11, 2026
Novel pleiotropic loci links vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenonCarlos Rangel-Peláez, Inmaculada Rodriguez-Martin, Carlos Rosa-Baez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 1, 2017
Analysis of ATP8B4 F436L Missense Variant in a Large Systemic Sclerosis CohortElena López-Isac, Lara Bossini-Castillo, Ana B Palma, et al.
The Lancet. Rheumatology|April 18, 2026
Sex-specific autosomal susceptibility loci in systemic sclerosis: a genome-wide association studyInmaculada Rodriguez-Martin, Martin Kerick, Carlos Rangel-Peláez, et al.
Pageof 15